SBIR/STTR Research Award

Structurally Diverse Encoded Peptide Sets

Award identifier 70a9ce82b68a7cf56d947bc1eb9c404bd6df1c396eca0f59a8aa247c989fce95Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$151,352

Program and phase

SBIR · Phase I

Award year

2013

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
CELL MICROSYSTEMS INC
Proposal award date
Not reported
Contract end date
Not reported
UEI
G51EN7YDH7F3
Solicitation number
PA12-088
Topic code
NIGMS

Research abstract

DESCRIPTION (provided by applicant): Cell Microsystems is a North Carolina-based start-up biotechnology company whose mission is to commercialize a novel, yet affordable, platform for the efficient isolation of viable, single cells or colonies from a mixedpopulation while the cell/colony remains adherent or encapsulated to a solid surface. The company's IsoRaft technology is based on a unique cell array recently developed at the University of North Carolina (UNC) at Chapel Hill, and represents an ideal opportunity for the translation of an academic technology to the marketplace through the SBIR program. Cell Microsystems has obtained license from UNC to commercialize the technology for a broad market in academic labs, as well as in the biotechnology and pharmaceutical industries. The products consist of disposable microarray (the IsoRaft Array) for culturing cells and a simple device for isolating the cell/colony of interest. Prototypes of arrays and devices have been completed and are being tested in a number of academic labs as an Early Adoption Program (EPA) at nearby research institutes. In this Phase I SBIR proposal, we will explore the feasibility of using the IsoRaft technology for stem cell research. Particularly we will focus on design and optimize the IsoRaft Array for stem cells, and develop strategies for cell imaging, identification, tracking and retrievl of targeted stem cells/colonies. The use IsoRaft technology for stem cell research will be conducted by our academic collaborator at UNC School of Medicine. Our goal is to expand the use of this technology for stem cell research to the large community in the life science market. The studies in Phase I will deliver a 1st generation commercial device and consumables that provide a flexible and powerful means to perform unique stem cell assay and sorting experiments at significant cost and time reduction. PUBLIC HEALTH RELEVANCE PUBLIC HEALTH RELEVANCE: The novel cell sorting technology being developed by Cell Microsystems Inc. will havebroad applications in various health and scientific related area of research.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

19 SBIR/STTR records share this UEI (2013–2023). Reported award amounts total $15,051,342. Reported amounts are not federal obligations.

Phases: Phase I, Phase II, Phase II – Direct to Phase II

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.